MultiPlan ROE 2019-2024 | MPLN
Current and historical return on equity (ROE) values for MultiPlan (MPLN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| MultiPlan ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $-1.54B | $0.21B | -166.83% |
| 2024-06-30 | $-1.17B | $0.60B | -89.60% |
| 2024-03-31 | $-0.63B | $1.17B | -39.45% |
| 2023-12-31 | $-0.09B | $1.71B | -5.19% |
| 2023-09-30 | $-0.71B | $1.75B | -40.01% |
| 2023-06-30 | $-0.67B | $1.77B | -34.22% |
| 2023-03-31 | $-0.62B | $1.79B | -29.25% |
| 2022-12-31 | $-0.57B | $1.79B | -25.34% |
| 2022-09-30 | $0.10B | $2.44B | 4.30% |
| 2022-06-30 | $0.16B | $2.41B | 6.78% |
| 2022-03-31 | $0.10B | $2.39B | 4.24% |
| 2021-12-31 | $0.10B | $2.35B | 4.33% |
| 2021-09-30 | $-0.10B | $2.36B | -3.99% |
| 2021-06-30 | $-0.46B | $2.34B | -22.19% |
| 2021-03-31 | $-0.47B | $2.38B | -26.69% |
| 2020-12-31 | $-0.52B | $2.56B | -36.17% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.259B | $0.962B |
| MultiPlan, Corp. provides solutions for healthcare. The company offers Services, such as medical payment integrity, dental payment integrity services, network-based services as well as analytics-based service. It serves commercial, property and casualty and government markets. MultiPlan, Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $90.619B | 11.24 |
| Cencora (COR) | United States | $47.732B | 17.95 |
| DiDi Global (DIDIY) | China | $22.844B | 0.00 |
| Natera (NTRA) | United States | $22.698B | 0.00 |
| ICON (ICLR) | Ireland | $16.752B | 14.92 |
| Avantor (AVTR) | United States | $15.042B | 22.55 |
| Revvity (RVTY) | United States | $14.943B | 25.96 |
| BioMerieux (BMXMF) | France | $13.831B | 0.00 |
| Viatris (VTRS) | United States | $13.297B | 4.10 |
| CochLear (CHEOY) | Australia | $13.090B | 0.00 |
| Solventum (SOLV) | United States | $12.725B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.729B | 30.23 |
| Doximity (DOCS) | United States | $10.460B | 61.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.632B | 0.00 |
| HealthEquity (HQY) | United States | $9.166B | 45.99 |
| Charles River Laboratories (CRL) | United States | $8.602B | 16.62 |
| Sonic Healthcare (SKHHY) | Australia | $8.397B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| Bausch + Lomb (BLCO) | Canada | $6.016B | 27.98 |
| Organon (OGN) | United States | $4.087B | 4.12 |
| Sotera Health (SHC) | United States | $3.852B | 20.61 |
| BrightSpring Health Services (BTSG) | United States | $3.690B | 78.48 |
| Concentras Parent (CON) | United States | $2.819B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.801B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.587B | 29.49 |
| PACS (PACS) | United States | $2.147B | 0.00 |
| Premier (PINC) | United States | $2.116B | 11.01 |
| GeneDx Holdings (WGS) | United States | $2.082B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.075B | 0.00 |
| Progyny (PGNY) | United States | $1.801B | 36.47 |
| GoodRx Holdings (GDRX) | United States | $1.795B | 47.10 |
| Teladoc Health (TDOC) | United States | $1.701B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.658B | 0.00 |
| Agilon Health (AGL) | United States | $1.463B | 0.00 |
| CareDx (CDNA) | United States | $1.244B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.208B | 11.82 |
| Embecta (EMBC) | United States | $1.089B | 7.62 |
| AMN Healthcare Services Inc (AMN) | United States | $1.022B | 6.91 |
| Establishment Labs Holdings (ESTA) | $1.014B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.609B | 0.00 |
| SBC Medicals (SBC) | United States | $0.521B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.501B | 0.00 |
| DocGo (DCGO) | United States | $0.448B | 16.89 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.426B | 11.15 |
| Enhabit (EHAB) | United States | $0.398B | 34.39 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.255B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.220B | 0.00 |
| LifeMD (LFMD) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.207B | 0.00 |
| Nutex Health (NUTX) | United States | $0.207B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.189B | 0.00 |
| Biodesix (BDSX) | United States | $0.145B | 0.00 |
| So-Young (SY) | China | $0.105B | 17.80 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| ModivCare (MODV) | United States | $0.077B | 4.20 |
| IceCure Medical (ICCM) | Israel | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Oncology Institute (TOI) | United States | $0.053B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| OncoCyte (OCX) | United States | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
| KindlyMD (KDLY) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |